SCHEMBL12025762

SCHEMBL12025762

Brc1ccc(-c2cc3ccc4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.43
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 3/20 0.41
CYP1B1 Q16678 2/20 0.41
CYP1A1 P04798 1/20 0.41
CYP2A6 P11509 2/20 0.41
ALDH1A1 P00352 7/20 0.39
HSD17B10 Q99714 4/20 0.39
HPGD P15428 4/20 0.39
MAPK1 P28482 2/20 0.39
TSHR P16473 2/20 0.39
HIF1A Q16665 2/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474235 0.83 MAOA (0.41) KDM4EMEN1KMT2ACYP1A2CYP2A6
SCHEMBL18088198 0.81 ADORA3 (0.44) GRM2KDM4EMEN1KMT2ACYP1A2
SCHEMBL2900877 0.81 CYP1A2 (0.40) KDM4EMEN1KMT2ACYP1A2CYP1B1
SCHEMBL895891 0.81 CYP11B1 (0.50) GRM2KDM4EMEN1KMT2ACYP1B1
SCHEMBL29596315 0.81 CYP11B1 (0.50) GRM2KDM4EMEN1KMT2ACYP1B1
SCHEMBL2903602 0.80 GSTP1 (0.46) KDM4EMEN1KMT2ACYP1A2CYP1B1
SCHEMBL29237184 0.80 ALDH1A1 (0.43) GRM2CYP1A2CYP1B1CYP1A1CYP2A6
SCHEMBL23697444 0.79 CYP11B1 (0.49) GRM2KDM4EMEN1KMT2ACYP1B1
Benzene SCHEMBL21624613 0.79 GRM2 (0.50) GRM2KDM4EMEN1KMT2ACYP1A2
SCHEMBL29772982 0.79 CYP11B1 (0.49) GRM2KDM4EMEN1KMT2ACYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-9126887-B2 Organic electroluminescent element material and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
US-9126887-B2 Organic electroluminescent element material and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-20110303907-A1 ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-12-15 US disclosed
US-20110303907-A1 ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-12-15 US disclosed
EP-2378585-A1 ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME Idemitsu Kosan Co., Ltd. (JP) 2011-10-19 EP disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME NRAS, RSU1, RAP1A GRM2 2866/4885KDM4E 2401/4885MEN1 1369/4885
US-20110303907-A1 ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME L1CAM, EPCAM, LEF1 GRM2 2548/4885KDM4E 1581/4885MEN1 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.